As CHK2 is the main substrate of ATM that becomes phosphorylated after dox treatment (Fig. 1a), and since previously CHK2 was proposed to be responsible for p53-independent senescence of cancer cells18, we silenced CHK2 expression (Fig. 5c). This evidence concerns the gene TP53 and cancer.